ES2910226T3 - Inhibidores de desmetilasa de histonas - Google Patents

Inhibidores de desmetilasa de histonas Download PDF

Info

Publication number
ES2910226T3
ES2910226T3 ES15842574T ES15842574T ES2910226T3 ES 2910226 T3 ES2910226 T3 ES 2910226T3 ES 15842574 T ES15842574 T ES 15842574T ES 15842574 T ES15842574 T ES 15842574T ES 2910226 T3 ES2910226 T3 ES 2910226T3
Authority
ES
Spain
Prior art keywords
pyrimidin
pyrido
phenoxy
methyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES15842574T
Other languages
English (en)
Spanish (es)
Inventor
Amogh Boloor
Toufike Kanouni
Jeffrey Alan Stafford
James Marvin Veal
Michael Brennan Wallace
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celgene Quanticel Research Inc
Original Assignee
Celgene Quanticel Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Quanticel Research Inc filed Critical Celgene Quanticel Research Inc
Application granted granted Critical
Publication of ES2910226T3 publication Critical patent/ES2910226T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES15842574T 2014-09-17 2015-09-16 Inhibidores de desmetilasa de histonas Active ES2910226T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462051691P 2014-09-17 2014-09-17
PCT/US2015/050432 WO2016044429A1 (en) 2014-09-17 2015-09-16 Histone demethylase inhibitors

Publications (1)

Publication Number Publication Date
ES2910226T3 true ES2910226T3 (es) 2022-05-12

Family

ID=55525128

Family Applications (1)

Application Number Title Priority Date Filing Date
ES15842574T Active ES2910226T3 (es) 2014-09-17 2015-09-16 Inhibidores de desmetilasa de histonas

Country Status (17)

Country Link
US (7) US9643965B2 (cg-RX-API-DMAC7.html)
EP (2) EP3453710B1 (cg-RX-API-DMAC7.html)
JP (1) JP6552608B2 (cg-RX-API-DMAC7.html)
KR (1) KR20170048591A (cg-RX-API-DMAC7.html)
CN (1) CN107205391A (cg-RX-API-DMAC7.html)
AU (1) AU2015317806A1 (cg-RX-API-DMAC7.html)
BR (1) BR112017005511A2 (cg-RX-API-DMAC7.html)
CA (1) CA2961610A1 (cg-RX-API-DMAC7.html)
CL (1) CL2017000659A1 (cg-RX-API-DMAC7.html)
CO (1) CO2017003538A2 (cg-RX-API-DMAC7.html)
EA (1) EA201790603A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP17023551A (cg-RX-API-DMAC7.html)
ES (1) ES2910226T3 (cg-RX-API-DMAC7.html)
IL (1) IL251179A0 (cg-RX-API-DMAC7.html)
MX (1) MX2017003466A (cg-RX-API-DMAC7.html)
SG (1) SG11201702147TA (cg-RX-API-DMAC7.html)
WO (1) WO2016044429A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE034906T2 (hu) 2013-03-15 2018-03-28 Quanticel Pharmaceuticals Inc Hiszton-demetiláz inhibitorok
JP6552608B2 (ja) 2014-09-17 2019-07-31 セルジーン クオンティセル リサーチ,インク. ヒストンデメチラーゼ阻害剤
WO2017161012A1 (en) 2016-03-15 2017-09-21 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
US10150754B2 (en) 2016-04-19 2018-12-11 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
JP6745905B2 (ja) 2016-11-28 2020-08-26 帝人ファーマ株式会社 ピリド[3,4−d]ピリミジン誘導体又はその溶媒和物の結晶
CA3056641A1 (en) 2017-03-29 2018-10-04 Purdue Research Foundation Inhibitors of kinase networks and uses thereof
AU2019387370A1 (en) 2018-11-30 2021-06-10 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
EP4074317A1 (en) 2021-04-14 2022-10-19 Bayer AG Phosphorus derivatives as novel sos1 inhibitors
CN115368252B (zh) * 2022-09-19 2024-01-12 西北农林科技大学 一种4-胺基酚类衍生物及应用
CN116253712B (zh) * 2023-03-27 2025-05-02 昆山市第一人民医院 5,6,7-三甲氧基-2,3-二氢喹啉类化合物、药物组合物及用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003033472A1 (en) * 2001-10-17 2003-04-24 Kirin Beer Kabushiki Kaisha Quinoline or quinazoline derivatives inhibiting auto- phosphorylation of fibroblast growth factor receptors
WO2003078427A1 (en) 2002-03-15 2003-09-25 Vertex Pharmaceuticals, Inc. Azolylaminoazines as inhibitors of protein kinases
JP2007501854A (ja) * 2003-05-27 2007-02-01 ファイザー・プロダクツ・インク 受容体型チロシンキナーゼ阻害薬としてのキナゾリン類およびピリド[3,4−d]ピリミジン類
JP2008510823A (ja) * 2004-08-23 2008-04-10 メルク エンド カムパニー インコーポレーテッド Akt活性阻害剤
FR2876103B1 (fr) 2004-10-01 2008-02-22 Aventis Pharma Sa Nouveaux derives bis-azaindoles, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
US20080221132A1 (en) 2006-09-11 2008-09-11 Xiong Cai Multi-Functional Small Molecules as Anti-Proliferative Agents
TW200922590A (en) 2007-09-10 2009-06-01 Curis Inc VEGFR inhibitors containing a zinc binding moiety
JP5552608B2 (ja) 2012-04-27 2014-07-16 株式会社ソフイア 遊技機
RS55764B1 (sr) 2012-10-02 2017-07-31 Gilead Sciences Inhibitori histonskih demetilaza
AU2013361255B2 (en) 2012-12-19 2017-01-05 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
AU2013363957B2 (en) 2012-12-21 2018-03-22 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
JP6320506B2 (ja) 2013-03-12 2018-05-09 セルジーン クオンティセル リサーチ,インク. ヒストンデメチラーゼ阻害剤
HUE034906T2 (hu) 2013-03-15 2018-03-28 Quanticel Pharmaceuticals Inc Hiszton-demetiláz inhibitorok
US20160143910A1 (en) 2013-03-15 2016-05-26 Constellation Pharmaceuticals, Inc. Methods of treating cancer and preventing cancer drug resistance
EP3738960A1 (en) 2014-06-25 2020-11-18 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
JP6552608B2 (ja) * 2014-09-17 2019-07-31 セルジーン クオンティセル リサーチ,インク. ヒストンデメチラーゼ阻害剤
US10030017B2 (en) 2014-09-17 2018-07-24 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
WO2017161012A1 (en) 2016-03-15 2017-09-21 Celgene Quanticel Research, Inc. Histone demethylase inhibitors

Also Published As

Publication number Publication date
CA2961610A1 (en) 2016-03-24
IL251179A0 (en) 2017-05-29
US20210009585A1 (en) 2021-01-14
CO2017003538A2 (es) 2017-07-28
US20190023704A1 (en) 2019-01-24
MX2017003466A (es) 2017-07-13
US9643965B2 (en) 2017-05-09
US10611763B2 (en) 2020-04-07
KR20170048591A (ko) 2017-05-08
US10112940B2 (en) 2018-10-30
JP2017529346A (ja) 2017-10-05
AU2015317806A1 (en) 2017-04-13
EA201790603A1 (ru) 2017-10-31
EP3453710B1 (en) 2022-09-21
CN107205391A (zh) 2017-09-26
US20200199122A1 (en) 2020-06-25
US20250066355A1 (en) 2025-02-27
EP3193601B1 (en) 2022-01-05
SG11201702147TA (en) 2017-04-27
ECSP17023551A (es) 2017-05-31
EP3193601A4 (en) 2018-07-04
US20160083379A1 (en) 2016-03-24
BR112017005511A2 (pt) 2018-08-14
WO2016044429A1 (en) 2016-03-24
CL2017000659A1 (es) 2018-05-11
US10815234B2 (en) 2020-10-27
US12172998B2 (en) 2024-12-24
EP3453710A1 (en) 2019-03-13
JP6552608B2 (ja) 2019-07-31
US20170240546A1 (en) 2017-08-24
US20230117519A1 (en) 2023-04-20
US11535616B2 (en) 2022-12-27
EP3193601A1 (en) 2017-07-26

Similar Documents

Publication Publication Date Title
ES2910226T3 (es) Inhibidores de desmetilasa de histonas
ES2718495T3 (es) Inhibidores de la histona desmetilasa
ES2862648T3 (es) Inhibidores de la histona desmetilasa
US10202381B2 (en) Histone demethylase inhibitors
BR112016025248B1 (pt) Compostos inibidores de demetilase lisina-específica-1, composição farmacêutica e seus usos
US10231957B2 (en) Histone demethylase inhibitors
ES2921009T3 (es) Inhibidores de desmetilasas de histonas